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Purpose: This study examined the efficacy of caffeine supplementation on tennis 
performance in male and female collegiate tennis players and whether a 
polymorphism of the CYP1A2 gene influenced the ergogenic response to caffeine.  
Methods: Eighteen collegiate tennis players (9 male; 9 female) completed two 
separate trials.  Each test occurred one hour after the administration of either 6 mg/kg 
of caffeine or a placebo, administered in double-blind fashion.  The treadmill portion 
was comprised of 15 minutes at a velocity corresponding with 50% VO2max followed 
by 30 minutes of intermittent sprints (5 seconds at 80% VO2max, 15 seconds at 50% 
VO2max).  90 second resting periods were administered after the 18
th
 sprint and every 
twelve sprints thereafter, mirroring the discontinuous nature of tennis.  RPE and HR 
was taken before each 90 second resting period.  120 seconds following the treadmill 
test, the tennis skills test was administered.  A 6-ball drill comprised with 4 
groundstrokes, 1 approach shot and 1 volley were fed, followed by a 20 second 
resting period.  The 6-ball drill was repeated 6 times, and every 2 sessions were 
followed by a 90 second break.  Nine full sessions were performed with RPE and HR 
recorded prior to resting periods.   Subjects completed these methods for both 
treatments, in a randomly counterbalanced, double-blind protocol.  DNA was 
obtained from whole blood samples and analyzed for presence of the C variant using 
polymerase chain reaction with allele-specific primers.  Subjects were classified as 
AA homozygotes (N=7) or C allele carriers (N=9).  Results: Caffeine significantly 
(P=0.029) improved performance during the Tennis Skills test.  There was no 
genotype effect (P=.454), regardless of gender. There was no main effect for 
vii 
 
treatment on RPE during the treadmill portion of the test and no significant main 
effects or interaction effects for RPE following ingestion of caffeine during the 
Tennis Skills Test.  A significant gender effect existed during the treadmill portion of 
the test (P=0.020) and Tennis Skills test (P=0.027) for RPE with women exhibiting a 
lower RPE men.  Furthermore, on average, caffeine elevated peak HR in AA 
homozygotes and lowered peak HR for C allele carriers. Conclusion: Caffeine 







 Prior studies have recognized notable ergogenic benefits of a large dose (5-6 
mg/kg) of caffeine supplementation for both aerobic and anaerobic performances 
(1,3,4,5,12,18,20,21,29,46,51,60)).  However, the effect of caffeine supplementation on 
tennis, a sport that combines aspects of aerobic and anaerobic activities, remains 
unknown.  One study by Hornery et al. (2007) included highly trained male subjects who 
performed simulated tennis matches against a ball machine in which caffeine was shown 
to partly attenuate the effects of fatigue and increased serve velocity (35).  On the 
contrary, a study by Ferrauti et al. (1997) included male and female subjects who 
ingested caffeine during the match.  Results indicated that caffeine did not positively 
affect perception ratings or hitting accuracy (26).  
 Caffeine is metabolized mainly by the polymorphic cytochrome P450 1A2 
(CYP1A2) enzyme (15) and the rate of metabolism varies between individuals (34).   
Studies have shown the presence of a C/A polymorphism in intron 1 of the CYP1A2 gene 
(57), with slower caffeine metabolism following caffeine ingestion in individuals 
possessing the C allele (57,15).  In an unpublished study, subjects homozygous for the A 
variant of the studied polymorphism had a more prominent ergogenic effect for 40 
kilometer cycling time during the caffeine trial than subjects possessing the C variant 
(67), suggesting AA homozygotes have an elevated caffeine response.  Whether 
possession of this genotype results in a greater ergogenic effect on tennis performance is 





supplementation in collegiate tennis players and whether the polymorphism may explain 
the different response to caffeine supplementation as an ergogenic aid in tennis 
performance.  The hypothesis was that caffeine will improve tennis performance in 
collegiate tennis players and that subjects homozygous for the CYP1A2*1A allele will 


















Review of Literature 
The ingestion of caffeine prior to physical activity has elicited ergogenic effects for 
both aerobic and anaerobic sports.  A substantial amount of evidence exists supporting 
the ergogenic effects of caffeine on aerobic sports which are addressed in Table 1.  
Anaerobic performance improvements are less established than endurance performance.  
Equivocal effects of caffeine intake on performance during anaerobic exercise have been 
observed (Table 2).  Literature exists demonstrating enhanced performance following 
caffeine supplementation; no effect on performance following caffeine ingestion; as well 
as varied effect on performance following the ingestion of caffeine during anaerobic 
exercise.   
Tennis is a unique sport in that it includes all three energy systems - high energy 
phosphates, anaerobic-glycolytic processes and aerobic energy system (55).  Although 
there is an abundance of literature surrounding caffeine‟s effect on aerobic and anaerobic 
sports, few studies exists which cover sports that combine aspects of both aerobic and 
anaerobic activities and also include a skill component.  Furthermore, an even more 
limited amount of information exists that is directly related to caffeine and tennis 
performance (Table 3). 
Lastly, evidence illustrating that the mode of exercise, dosage of caffeine and 
characteristics of the subjects - trained versus untrained, may have an effect on caffeine‟s 







 Table 1 illustrates the ergogenic effects of caffeine during endurance activities.    
Twelve of these studies were conducted using a cycle ergometer.  Some of these studies 
used time trials varying from sprint distances to exercise trials lasting 3 or more hours.  
Furthermore, male subjects were used in ten of these studies.  All of these studies elicited 
a performance enhancement following caffeine ingestion. 
 There are five studies that observed a performance enhancement following 
caffeine ingestion using a treadmill protocol.  Each of these high-intensity endurance 
studies, regardless of distance, demonstrated an ergogenic effect of caffeine.  In one 
study, an ergogenic effect was observed at a dosage of 150 ml/l and even greater with the 
medium dosage of 225 mg/l.  However, the highest dosage (320 mg/l) did not further 
improvement as compared to the medium dosage (46).  
 Although the methodology and protocols used for each study varies, the ingestion 
of caffeine prior to activity has been identified as the catalyst supporting the enhanced 
performance.   
 












To determine the effect of 
combined ingestion of 
glucose and caffeine 
during 2h of cycling on 
exogenous CHO 
oxidation rates. 
Eight trained male 
cyclists 
3 exercise trials 
consisting of 120 min 
of cycling at 55% 
Wmax.  Received 
either a glucose drink, 
glucose + caffeine or 
plain water.  Trials 
separated by 1 wk 
Glu + Caf during 
exercise resulted in 
higher exogenous 
CHO oxidation 


















To study the effects of 
low doses of caffeine (~2 
cups of strong coffee) on 
a number of factors 
1. Eighteen male 
local middle 
distance athletes                        
2. Ten athletes                    
3. Six male middle 
distance athletes 
1. 9 time trials of 
1500m on treadmill         
2. run for 1100m at 
1km/h, final 400m 
bursts for final minute  
3. 9 runs - 3 test and 6 
assessment: 3 three 
following caffeinated 
coffee and 3 with 
decaffeinated coffee                                   
Small doses of 









Sprint Ability in 
Team-Sport 
Athletes (60) 
To examine the effects of 




10 male team-sport 
athletes 
Two exercise trials, 
separated by 7d, 60 
min after ingestion of 
either 6 mg/kg caff or 
placebo - trials 
performed on cycle 
ergometer 2 x 36-min 
halves, each composed 
of 18 x 4-s sprints with 
2-min active recovery 



















To analyze the effects of 
caffeine ingestion on the 
slow component of 
oxygen uptake during 
high-intensity endurance 
exercise 
Nine subjects (8 
male; 1 female) 
Two 9-min tests on a 
treadmill at 90% 
VO2max, 60 min after 
ingesting either Pla or 
Caf capsule 
Ergogenic effect of 
caffeine in a high-
intensity 
endurance exercise 
may be partly 
mediated by 
attenuation of VO2 
slow component 








To investigate the effects 
of caffeine ingestion on 
exercise performance in 
rats and athletes 
1. 48 male rates 3 
wk of age                                  
2. 5 healthy rubgy 
players 
1. Rats ingested Caff 1 
h before exercise, run 
on treadmill at 
20m/min   2. Humans 
ingested Caff 1 h 
before exercise, 
exercised on cycle 
ergometer at 60% 
VO2max for 45 min 
then intensity 
increased to 80% until 
exhaustion 
RER Caff < Pla in 
athletes; FFA Caff 
> Pla for both rats 
and athletes; 
Lactate levels 
increased for both 
during exercise; 




ex vs. Pla for rats; 
time to exhaustion 
significantly 
increased by Caff 















To examine the effect of 
caffeine ingestion on 
muscle glycogen 






subjects given Pla or 
Caff in double blinded 
manner 90 min before 
cycling for 2 h at 65% 
their VO2max 
Caff ingestion 90 
min before 
prolonged exercise 
does not exert 
muscle glycogen-
sparing effect in 





and cortisol release 
















To determine whether 
caffeine ingestion prior to 
graded exercise 






tests until exhaustion 
on a cycle ergometer 
at room temp (22 
degrees C or in the 
cold -20 degrees C).  
Ingestion of either 2 
cups of caffeinated or 
decaff coffee 1 hr prior 
to exercise 
Beneficial effect of 
caffeine on the LA 
threshold occurs in 
majority of 
subjects exercising 
at room temp, but 









To investigate the effects 
of ingesting caffeine, 
ephedrine, and their 
combination on muscular 
endurance 
13 male subjects 90 min after ingesting 
either C, E, or a 
combination of  C+E 
or a placebo, 
performed weight-
training circuit 
consisting of three 
supersets, each 
consisting of leg press, 
followed by bench 
press with 2 min rest 
between supersets 
Trials involving 
C+E and E, when 
compared to C and 
P, caused 
significant 
increases in the 
mean number of 
repetitions 
completed for both 
the leg-press and 
bench-press 
exercises but only 




to E, no additive 








To examine the possible 
effects of caffeine 
ingestion on muscle 
metabolism and 




Ingested either Pla or 
Caf (6 mg/kg), cycled 
for 2 min, rested 6 
min, cycled 2 min, 
rested 6 min, and then 
cycled to exhaustion. 
Caffeine ingestion 
can be an effective 
ergogenic aid for 
exercise around 5 












To investigate the 
ergogenic and metabolic 
effects of theophylline 
and caffeine: a) the 
ergogenic potential of 
theophylline on 
endurance exercise      b) 
effects of Theo on muscle 
metabolism were 
investigated and 
compared with caffeine 
a) Eight men                                     
b) Seven men 
a) cycle at 80% 
VO2max to exhaustion 
90 min after ingesting 
either placebo, 
caffeine, or 
theophylline         b) 
cycle at 70% 
VO2max, followed by 
same treatment as Part 
A 
Ingestion of Theo 
resulted in 14% 
increase in 
performance 
during whole body 















To review existing 
literature regarding 
caffeine and athletic 
performance 
A review of 
literature 
A summarization of 
existing literature 
Caffeine ingestion 







cycling & decrease 
swim time for 
1500m.  These 
results are reported 
in well-trained 
athletes but field 
studies are lacking 
to confirm effects 
in the athletic 
world 
Effects of 
caffeine on time 







To compare the effects of 
caffeine ingestion on 
endurance performance 
during exercise on a 
bicycle ergometer, 10% 




Cycled to exhaustion - 
once 10% above AT 
and another 10% 
below AT.  Each 
intensity performed 
twice following 
ingestion of Caf (5 















To examine the effects of 
different protocols of 
caffeine on cycling 
performance 
a) Twelve subjects                
b) Eight subjects 
a) Subjects received 
either decaf 1hr before 
exercise, 6 doses every 
20 min, 2 doses 
between 100 and 120 
min SS, or placebo         
b) Subjects received 3 
doses of caff during 
last 40 min SS and TT 
Coke enhanced TT 




timing of intake; 
replacing sports 
drink with Coke 
during latter stages 




performance due to 


















To compare the effects of 
a single and divided dose 
of caffeine on endurance 
performance and on 
postexercise urinary 
caffeine and plasma 
paraxanthine 
concentrations 
Nine male cyclists Cycle for 90 min at 
68% VO2max, 
followed by self-paced 
time trial at 80% 
VO2max for 30 min 
with three 
interventions: placebo, 
single caffeine dose or 
divided caffeine dose 
60 min before and 45 
min during exercise 






lower in CC 




dependent with no 
peak during 
exercise: dividing 
caffeine dose does 
not provide an 
ergogenic effect 









a field setting 
(8) 
To investigate the effect 
of caffeine ingestion on 
8km run performance 
using an ecologically 
valid field test 
Eight trained male 
distance runners 
Three trials separated 
by one week of an 8 
km race run as quickly 
as possible 1 h after 
ingesting placebo, 
caffeine capsule (3 




8 km run 
performance in a 






To determine the 
physiological effects of 




subjects (5 male, 5 
female) 
2 30-min runs at 70% 
VO2max on the 
treadmill, 1 h after 
ingesting caffeine or 
placebo 
Decreased 
perception of effort 
with caffeine 
ingestion; caffeine 













To examine the effect 
repeated doses of caffeine 
on repeated exercise 
endurance 
Nine male subjects Subjects ingested 
either caffeine or 
placebo 1 hr before 
exercise ride; ER to 
exhaustion 80% 
VO2max two times 
per day - 4 treatments 
with different 
combination of 









effect of the drug 
during subsequent 
exercise 6 h later 
Exercise 
endurance 1,3, 






To examine the duration 
of caffeine's ergogenic 
effect and whether it 
differs between users and 




exercise rides to 
exhaustion at 80% of 
maximal oxygen 
consumption after 
ingesting either a 
placebo or caffeine - 
1,3, or 6 h after 
placebo or drug 
ingestion 
Exercise times 1 
and 3 h after 
caffeine intake 
greater than 




following 5 mg/kg 














To objectively evaluate 
studies that have 
examined the effect of 
caffeine on time-trial 
endurance performance 
(>5 min)  
Twenty-one studies 




performance with a 
time-trial aspect 
Each study objectively 
analyzed with PEDro 
scale 
Abstaining from 
caffeine at least 7 
days before use 












To test whether caffeine-
induced changes in 
metabolic and 
catecholamine responses 
are less pronounced  
during periods of chronic 
caffeine ingestion, thus 
influencing the ergogenic 
response to caffeine 
ingestion 
Six recreational 
male athletes who 
were habitual 
caffeine users 
7 exercise trials to 
exhaustion, 10 days 
betewen trials.  First 2 
trials without caffeine 
withdrawal - assigned 
randomly with placebo 
or caffeine.  
Subsequent trials after 










vs. no withdrawal; 
responses to acute 
caffeine ingestion 
during w/d on 
FFAs and NE but 
no effect on 










To determine the effect of 
addition of different 
dosages of Caf to a CHO-




Fifteen healthy and 
well-trained male 
subjects 
Ingestion of Pla, 7% 
Pla-CES, or 7% CS 
with 150, 225, and 
320-mg/l Caf during 
20-m warm up 
protocol and 3 ml/kg 
at 1/3 and 2/3 of a 1-h 
time trial 
Performance was 





dosage did not 





 There exists an abundance of information illustrating the effect of caffeine 
ingestion on anaerobic sports.  Although the majority of information suggests an 
enhanced performance following caffeine ingestion, some studies show no effect.  
According to a study on male cyclists, caffeine did not affect RPE or heart rate during the 
first stages of the test.  The ingestion of caffeine did, however, have an ergogenic-effect 
during the last minute of the preloaded cycle test (24).  A study by Beck et al., (2006) 
also reported significant increase in anaerobic performance following caffeine ingestion 
(2).  This study noted an increase in bench press 1RM, suggesting caffeine ingestion to be 





(1999), reported increased isometric leg extension strength and maintenance of 
submaximal leg extension contractions following caffeine intake (44).      
 Some studies show no effect on performance following caffeine ingestion for 
healthy subjects.  Collomp et al. (1991), reported that caffeine supplementation an hour 
and a half prior to testing had no effect on peak power during a Wingate Anaerobic Test 
(13).  Although this study incorporated a caffeine intake of 5 mg/kg, which is the 
approximate level of caffeine recorded to elicit an ergogenic effect in most studies, the 
extended timeframe of an hour and a half between intake and activity may explain the 
lack of effect.   
 Other studies show a varied effect of caffeine supplementation on performance 
dependent on the skill level of the athlete.  Collomp et al. (1992) reported an increase in 
maximal swimming velocity following caffeine ingestion for trained subjects, but 
untrained swimmers did not experience this benefit (12).     
 













To examine the 
involuntarily elicited and 
volitional neuromuscular 
contractile and electrical 
properties of skeletal 
muscle in men with 
habitual (>500 mg/day) 
and nonhabitual caffeine 
Twelve men with 
habitual (>500 mg/day) 




assigned to Caf or Pla in 
double-blind study, 100 
min before a 2-min tetanic 
stimulation of the 
common peroneal nerve - 
2 trials each of 20 and 40 
Hz 
Caffeine potentiated the 
force of contraction 
during the final minute 
of the 20-Hz 
stimulation with no 
effect of habituation; no 
effect of Caf on 40-Hz 
stimulation strength nor 
maximal voluntary 













To investigate effects of 
caffeine in a performance 
test simulating physical 
and skill demands of a 
rugby union game 
Nine high-level amateur 
rubgy union players 
double-blind, randomized, 
crossover design - 
Ingested either Caf or Pla 
70 min before test (seven 
circuits in each of two 40-
min halves with 10-min 
half-time rest) 
sprint speeds; first-drive 
power; passing 




to fatigue by 
maintaining 







To examine single motor 
unit firing rates during 
intermittent submaximal 
contractions and to 
determine whether 
administering caffeine 
increased time to fatigue 
(Tlim) by maintaining 
higher firing rates 
Ten male volunteers randomized, double-blind, 
repeated measures - 2 
separate days 50% max 
voluntary contractions of 
quads to Tlim, 1 h after 
ingesting Caff or Pla 
Rates didn't decline 
during intermittent 
contractions in control 
condition and the 
increase in Tlim in Caff 
couldn't be explained 





To examine the effects of 
caffeine on 
neuromuscular function 
Eleven male volunteers 10 x 1-ms stimulation of 
the tibial nerve to elicit 
maximal voluntary 
contraction of the right 
knee extensors, six brief 
submax contractions and 
50% MVC held to fatique 
Voluntary activation at 
MVC increased, but 
there was no change in 
H-reflex amplitude - 
Caf increased max 









To determine the effects 
of caffeine ingestion on a 
preloaded protocol  
Eleven male cyclists 2 min constant rate of 
100% max power output 
followed by 1-min all out 
effort - conducted test 
after comsuming placebo 
or caffeine 
Caffeine ingestion 
didn't affect heart rate 
or RPE during 12-min 
warmup.  Moderate 
amount of caffeine can 
have ergogenic effect 
during last min of 










To determine whether 
specific training (trained 
vs. untrained) is 
necessary to produce 
benefits from acute 
ingestion of caffeine by 
improving maximal 
anaerobic capacity during 
a spring swimming test 
Fourteen subjects - 7 
trained subjects and 7 
untrained subjects 
each subject swam on two 
different occasions 2 x 
100 m distances of 
freestyle at maximum 
speed and separated by 20 
min passive recovery, 
once after ingestion of Caf 
(250 mg) and once after 
placebo  
Benefits of the 
ingestion of caffeine 
during supramaximal 
exercise requiring high 
anaerobic capacity 
















To examine the acute 
effects of a caffeine-
containing supplement on 
upper and lower body 
strength and muscular 





assigned to supplement 
group or placebo group - 
after 1 hr of ingestion, 
subjects performed 2 
Anaerobic Tests and 1RM 
and muscular endurance 
tests 
Significant increase in 
1RM for Supp group; 
caffeine-containing 
supplement may be 
effective supplement 
for increasing upper-
body strength (no effect 
on lower-body strength, 
muscular endurance, 
anaerobic capabilities 
or upper-body muscular 









Sprint Ability in 
Team-Sport 
Athletes (60) 
To examine the effects of 




10 male team-sport 
athletes 
Two exercise trials, 
separated by 7d, 60 min 
after ingestion of either 6 
mg/kg caff or placebo - 
trials performed on cycle 
ergometer 2 x 36-min 
halves, each composed of 
18 x 4-s sprints with 2-
min active recovery at 



















To determine the effects 





Six healthy volunteers 60 min before each trial 
(two Wingate Anerobic 
Tests), ingested 5 mg/kg 
caffeine or placebo - 




but fails to improve 
performance during 
Wingate Anaerobic 





 A limited number of studies study the effect of caffeine supplementation which 
incorporates aspects of aerobic activities, anaerobic activities as well as a skill 
component.  To-date, there are two studies that observe the effect of caffeine ingestion on 
tennis performance, a sport containing these aforementioned qualities.  In one of these 
studies using a group of male tennis players, caffeine ingestion prior to activity enhanced 





(1997), found that caffeine didn‟t significantly affect RPE or hitting accuracy, however 
female subjects won more games during the caffeine treatment (26). 
 




studied Participants Procedures Findings 
Caffeine, 
carbohydrate, 





To determine the effects 
of prolonged simulated 
tennis on performance 
and the ergogenic 






(18.3 years old; 
+/-3 years) 
4 simulated matches 






solution), pre-cooling and 
intermittent cooling, and 
placebo. 
Caffeine increased 
serve velocity in the 
final set of the match 
compared with placebo 
and CHO conditions.  
Caffeine also partly 









To investigate the 
metabolic and ergogenic 
effects of carbohydrate 
and caffeine 
concentrations 







carbohydrate or caffeine 
drink at court changeover 
and during  the resting 
period during 4 hours 
interrupted tennis match.  
Men  (women) total intake 
was 2.8 l (2.0 l) fluid, 
supplemented with 243 g 
(182 g) carbohydrates or 
with 364 mg (260 mg) 
caffeine.  Post-exercise, 
players performed a ball-
machine test 
RPE and hitting 
accuracy were not 
affected by treatment.  
Under caffeine, women 
won significantly more 




 Studies have observed the effect of caffeine ingestion on performance during 
aerobic and anaerobic activities by incorporating a variety of exercise modes.  The 
majority of these studies used a cycling or running protocol.  There are other studies 
using a swimming protocol as well as one study that observed the ergogenic effect of 
caffeine during a game of rugby that enhanced the subjects‟ sprint speeds, drive power 





 The caffeine dosage also fluctuated throughout each study providing information 
relative to the optimal level of caffeine to be ingested in order to enhance performance.  
Studies have recognized notable ergogenic benefits when ingesting doses around 5-
6mg/kg of caffeine for both aerobic and anaerobic performances, while lower or higher 
dosages have fewer instances in which an enhanced performance is recognized.  A study 
by Graham et al. (1995), using a treadmill protocol observed that supplementation with 9 
mg/kg caffeine did not further improve performance as compared to the 3 and 6 mg/kg 
doses, while the 6 mg/kg dosage elicited the greatest performance enhancement (31). 
 Few studies exist supporting the effect of habitual caffeine intake on the 
ergogenic effect of caffeine.  Bell et al. (2002) found that both duration and magnitude of 
exercise are enhanced following 5 mg/kg caffeine in nonusers versus habitual caffeine 
users (5).  Another study found that caffeine administered to low to moderate caffeine-
consuming athletes was not associated with neuromuscular or metabolic changes that 
could be considered ergogenic to running performance (63).  This could be due to the 
subjects‟ tolerance to habitual caffeine consumption.     
Table 4: The effect of various modes of exercise, dosages and frequency of caffeine intake that effect the 




studied Participants Procedures Findings 
Ergogenic 






To learn whether low 
doses of caffeine have 
ergogenic, perceptual, 




Refrained from exercise 
24h & caffeine for 48h 
before testing. Ingested 
either placebo or one of 3 
treatments (1,2 or 3 mg/kg 
caffeine). After 60 min, 
cycled at 80% VO2peak 
followed by 15 min of 
cycling at all-out effort 
Caffeine doses of 2 and 
3 mg/kg enhance 
cycling performance 













To describe the effects of 
caffeine ingestion on the 
neuromuscular and 
metabolic responses to 
endurance running in 
subjects who were low-
mod-intake habitual 
caffeine consumers 
Six varsity level 
male runners 
6-d of preparation, then 
test day: 2h after 
consumption of meal 
arrived. Measurements of 
maximal voluntary 
isometric strength and 
evoked peak twitch torque 
or the right knee 
extensors. Subjects then 
ran for 90 min on a 
treadmill at 70%VO2max 
Caffeine admin in low-
mod habitual caff-
consuming athletes was 
not associated with 
neuromuscular or 
metabolic changes that 
could be considered 
ergogenic to endurance 
running performance - 
could be due to 





effects of coffee 
and caffeine 
ingestion (29) 
The impact of ingestion 
of the same dose of Caf 
in coffee consumption or 
in water 
Nine adults Ingested capsule (Caf or 
placebo) with water or 
Caf (decaff, decaff with 
Caf added, or reg cof); 
completed 5 trials running 
to exhaustion on treadmill 
at 85% VO2max - 1 week 
between trials 
Caffeine ingested in 
associated with coffee 
does not alter 
bioavailability of 









To review existing 
literature regarding 
caffeine and athletic 
performance 
A review of 
literature 
A summarization of 
existing literature 
Caffeine ingestion prior 






cycling & decrease 
swim time for 1500m.  
These results are 
reported in well-trained 
athletes but field 
studies are lacking to 










To examine the duration 
of caffeine's ergogenic 
effect and whether it 
differs between users and 
nonusers of the drug. 
Twenty-one 
subjects 
Six randomized exercise 
rides to exhaustion at 80% 
of maximal oxygen 
consumption after 
ingesting either a placebo 
or caffeine - 1,3, or 6 h 
after placebo or drug 
ingestion 
Exercise times 1 and 3 
h after caffeine intake 
greater than placebo 
trials; both duration and 
magnitude of ergogenic 
effect following 5 
mg/kg caffeine greater 















To determine the effect of 
addition of different 
dosages of Caf to a CHO-







Ingestion of Pla, 7% Pla-
CES, or 7% CS with 150, 
225, and 320-mg/l Caf 
during 20-m warm up 
protocol and 3 ml/kg at 
1/3 and 2/3 of a 1-h time 
trial 
Performance was 
improved with Caf 
supplementation 
(Greatest results with 
medium dosage; 
highest dosage did not 





 Caffeine is metabolized mainly by cytochrome P450 1A2 (CYP1A2) (15) and the 
rate of metabolism varies between individuals (34).  Studies have shown the presence of 
a C/A polymorphism in intron 1 of the CYP1A2 gene (57), with a slower caffeine 
metabolism following caffeine ingestion in individuals possessing the C allele (15,57).  
For subjects possessing the C allele, caffeine intake is associated with increased risk of 
nonfatal myocardial infarction, unlike those individuals homozygous for the 
CYP1A2*1A allele (15).  According to Womack et al. (2009), subjects homozygous for 
the A variant of the studied polymorphism had a more prominent ergogenic effect for a 
cycling time trial during the caffeine trial than subjects possessing the C variant (67), 


























studied Participants Procedures Findings 
Functional 
significance of 
a C --> A 
polymorphism 
in intron I of the 
cytochrome 
P450 CYP1A2 
gene tested with 
caffeine (57) 
To determine how much 
of the variability of 
CYP1A2 activity is due 
to a newly discovered 
gene polymorphism in 
intron 1 
185 healthy Caucasian 
non-smokers and 51 
smokers 
1. Using DNA sequence 
analysis by genotyping 
and phenotyping using 
100 mg oral dose of 
caffeine immediately 
following emptying of the 
bladder and collecting 
urine for the subsequent 5 
hours.  Urine 
concentrations of caffeine 
(137X) and the CYP1A2 
catalyzed metabolites 1.7-
dimethylxanthine (17X) 
and 1.7-dimethyluric acid 
(17U) was quantified by 
h.p.l.c.  the urine ratio was 
used as the index of 
CYP1A2 activity 2) 51 
smokers received 100 mg 
oral dose of caffeine and 
venous blood sample take 
5 hours after 
administration.  Molar 
metabolic concentration 
ration 17X/137X was 
used as the index of 
CYP1A2 activity. 
The A/A genotype, 
which could represent a 
CYP1A2 high 
inducibility genotype, 
may be a direct cause 
of increased CYP1A2 
activity or genetically 
linked to 
polymorphisms giving 








To determine the effects 
of CYP1A1 and CYP1A2 
genotypes on risk of 
myocardial infarction and 
whether smoking 
interacts with genotype to 
modify risk. 
873 subjects with a first 
acute non-fatal MI and 
population based 
controls (932) 
Subjects matched for age, 
sex, and area of residence 






smoking status was 
identified by 
questionnaire. 
The low inducibility 
genotype for CYP1A2 
was associated with an 
increased myocardial 
infarction, which was 
unrelated to smoking 
status and suggests that 
a substrate of CYP1A2 
that is detoxified rather 
than activated may play 















To investigate factors 
influencing the enzymes - 
cytochrome P450IA2, N-
acetyl transferase and 
xanthine oxidase, 
measured by the 
metabolite ratios of 
dietary caffeine. 
1) Cross-sectional: Urine 
samples collected from 
335 healthy volunteers - 
171 women 2) 
Longitudinal: urine 
samples collected from 
23 men before and after 
30 days with vigorous 
exercise, 8 hours per day 
3) Longitudinal: urine 
samples collected from 9 
healthy subjects after 
two 10-day periods with 
a diet supplemented with 
500 g green beans or 500 
g broccoli                                    
1) Cross-sectional: Urine 
samples collected from 
335 healthy volunteers - 
171 women 2) 
Longitudinal: urine 
samples collected from 23 
men before and after 30 
days with vigorous 
exercise, 8 hours per day 
3) Longitudinal: urine 
samples collected from 9 
healthy subjects after two 
10-day periods with a diet 
supplemented with 500 g 
green beans or 500 g 
broccoli                                   
In all 3 experiments, urine 
samples were taken prior 
to ingestion of at least one 
cup of coffee, within 2-6 
hours 
The ratio reflecting 
P450IA2 activity 
normally distributed.  
With smokers, ratio 
was 66% higher for 
male and 71% higher 
for female as compared 
to non-smokers.  Ratio 
reflecting the XO-
activity was normally 
distributed and smoking 
increases XO activity. 
30 days of vigorous 
exercise increased the 
IA2 ratio by 58%, 
NAT-ratio remained 
unchanged.  IA2 ratio 
increased with bean and 
broccoli 
supplementation and 
19% induction of 











To observe the 
association between 
phenotypes and 
genotypes of CYP1A2 
with respect to the two 
genetic polymorphisms. 
163 healthy Chinese 
volunteers living in 
Qidong 
The ratio of plasma 
17X/137X at 6 hours after 
orally ingesting 300 mg 
caffeine.  Genotyping 




polymorphism.   
The allele frequencies 
of A at 2964 were 0.25 
and A at 734 was 0.67 




734 genotype that was 
believed to have lower 
activity of CYP1A2 
than other genotypes 
did not exist in the 
subjects.  The G-2964 
and A734 was 
associated with the high 
activity of CYP1A2 in 
non-smokers and 
smokers, using the 








To determine whether 
CYP1A2 genotype 
modifies the association 
between coffee 
consumption and and risk 
of acute nonfatal MI. 
2014 cases with a first 
acute nonfatal MI and 
population-based 
controls living in Costa 
Rica, matched for age, 
sex, and area of 
residence.   




reaction.  Food frequency 
questionnaire sued to 
measure caffeinated 
coffee consumption. 
55% of subjects and 
54% of controls were 
carriers of the slow *1F 
allele.  Intake of coffee 
associated with an 
increased risk of 
nonfatal MI only 














To determine if a single 
nucleotide polymorphism 
(C/A) in the DNA 
sequence of the CYP1A2 
gene influences the 
ergogenic effect of 
caffeine supplementation. 
24 trained cyclists 1 h following ingestion of 
6 mg/kg of anhydrous 
caffeine or placebo 
(administered in a double-
blind fashion), subjects 
completed two short-
duration tests to fatigue 
(150% of VO2peak) and 
two 40k time trials on a 
cycle ergometer.  DNA 
obtained from whole 
blood samples and 
analyzed for presence or 
absence of C variant. 
Possession of the C 
variant negatively 
impacts the ergogenic 




























Twenty NCAA Division I tennis players (10 male; 10 female) (18-24 yrs), 
participating in daily tennis training and competition on the same tennis team, 
volunteered as subjects for this study.  Two subjects did not perform consistent training 
during the testing sessions (due to injuries) and two additional subjects were unable to 
complete the genotyping, and thus were dropped from the study results.  Preliminary 
statistical analyses were performed on the remaining 16 subjects.  Subject demographics 
are provided in Table 6. 
It was estimated that 10 of these subjects would be C allele carriers by observing 
the allele allotment in past literature (15).  Permission to recruit subjects from the tennis 
team was provided by the head coach.  Prior to the start of the study, all subjects signed 
an inform consent form (Appendix I) and completed a Health Status Questionnaire 
(Appendix II).  In addition, habitual caffeine intake was self-reported by subjects, by 
completing a second form, Caffeine Habits & Frequency Questionnaire (Appendix III) to 
determine their average weekly intake of coffee, tea, soda, chocolate, and other 
caffeinated beverages and/or food. Typical milligram doses were assigned to each subject 
according to Mayo Clinic (50) and an approximate daily intake was obtained.  Based on 
previous criteria (33), subjects were then characterized as having low (0-150 mg/day), 





Subjects had no known injuries that would impair tennis performance.  The James 
Madison University Institutional Review Board reviewed and approved all screening 
materials and experimental design prior to the beginning of data collection. 
Testing Procedures 
Maximal Exercise Test:  Subjects ran at a self-selected pace between 6.0-7.0 mph on the 
treadmill at 0% grade for 1 minute.  Every subsequent minute, grade was increased until 
the subject reached volitional fatigue.  Oxygen uptake was monitored continuously via a 
metabolic measurement system (Sensormedics Vmax: Yorba Linda, CA).   Heart rate was 
monitored using a Polar Heart Rate Monitor (Lake Success, NY).  Results from this test 
were used to determine appropriate exercise intensity for testing protocolss.   
Exercise Tests: A familiarization trial for the exercise tests was conducted prior to actual 
testing to enhance validity.  Subjects completed two separate exercise tests consisting of a 
treadmill test and a tennis skills tests (TST).  The tests were performed in the morning 
following a 12 hour fast.  The participants refrained from consumption of caffeine-
containing food and beverages for 24 hours prior to the tests.  One hour prior to testing, 
subjects ingested a capsule containing either 6 mg of anhydrous caffeine per kilogram of 
body weight or placebo (white flour), administered in double-blind fashion.  All tests 
were separated by a minimum of 48 hours.   
 Tennis is a repetitive sprint sport, with medium to high aerobic and anaerobic 
demands (25) and average exercise intensities ranging between approximately 60-70% 
VO2max (45).  Therefore, intensities above and below this range were used during the 





 The treadmill portion of the exercise test consisted of 15 minutes of a warm-up at 
a speed corresponding to 50% VO2max followed by 30 minutes of intermittent sprints. 
Tennis match play involves intermittent exercise bouts that alternate between short 
periods of high intensity of an average of 4-10 seconds and short recovery periods 
ranging between 10-20 seconds (25).  Therefore, to match the intermittent nature of the 
sport, subjects completed sprints for 5 seconds at a high intensity (80% VO2max), 
followed by 15 seconds of low intensity (50% VO2max) jogging between each sprint – a 
work to rest ratio of about 1:3.  Although the duration of play for each single point, game 
and match for a game of tennis is difficult to approximate due to differences in style of 
play, sex and level of play (25), the protocol was organized such that each sprint-jog 
sequence represented 1 point; with 6 sprint-jog sequences representing 1 game of tennis.   
 According to the International Tennis Federation (ITF), the official time between 
a change-over is 90 seconds (37) and the first change-over occurs after the first three 
games have been played.  Thereafter, a change-over would occur every two games.  As 
every 6 sprint-jog sequence represented 1 single game, the sprint-jog sequence was 
repeated eighteen times (3 games) followed by a 90 second rest period.  Subsequently, 
this sprint-jog sequence was repeated twelve times, followed by 90 seconds of rest as it 
represented two games of tennis.  This protocol was repeated for 30 minutes. 
 120 seconds following the treadmill portion of the exercise test, the TST was 
administered.  The 120 second rest represented the official allowable rest time between 
tennis sets (37).  The test is organized by sets of six different shots to emulate a single 
game within a set of tennis.  As the average number of shots during a single point of 





strokes (the stroke used the most within a tennis match), 1 approach shot and 1 volley 
closely embodies the skill component of a tennis match.  After each set of 6 balls, the 
subject actively rested at the baseline for 20 seconds, which represents the time allowed 
for rest between tennis points (37). The 6-ball drill was repeated 6 times, which 
represents a typical duration and number of balls for 1 game within a set of a realistic 
tennis match.  Every two sessions, the player had a 90 second break, the official time 
between a change-over during a match (37).  The athlete underwent 9 sessions, which 
represents 1 set of a typical tennis match.  The maximum number of successful shots for 
the TST was 324.  A successful shot was defined as each shot that landed in bounds.  
Each subject was then given a raw score out of a possible 324.  The key below simplifies 
the terminology used to describe the tennis skills test: 
 6 ball drill = 1 point of a typical match 
 6 repetitions of the 6-ball drill = 1 game of a typical match (6 reps of 6-ball drill 
= 1 session) 
 9 sessions = 1 set of a typical match 
 324 – maximum score 
 
 Tennis does not have time limits on matches, leading to high variability between 
lengths of any match.  In order to effectively emulate a realistic tennis match situation, a 
provisional time of 1.5 hours of exercise testing was used as this is a typical average 
match length (97).  The treadmill portion of the testing lasted 45 minutes, followed by an 
approximate length of 45 additional minutes of the tennis skills test.   
 Polar heart rate monitors were worn by all subjects during the exercise tests to 
obtain individual heart rates.  Rating of Perceived Exertion (RPE) was also obtained 
using the Borg RPE scale (Appendix IV).  During the treadmill portion of the test, heart 





measurements.  A tracking sheet was used to denote each sprint-jog and rest sequence for 
each subject along with their heart rate and RPE at the end of each resting period.  The 
subjects‟ respective running speeds, that were calculated according their VO2max scores 
were also recorded (Appendix V).   
   Heart rate and RPE was recorded after every two sessions throughout the tennis 
test and a final reading after the final session, for a total of four times during the tennis 
skills test.  Furthermore, a score sheet was used during the tennis tests to quantify 
successful shots (Appendix VI).  A timeline for data collection used for each trial are 
provided in Table 7.  To maintain consistency during testing, subjects were tested indoors 
to mitigate environmental factors.  Furthermore, ball feeding was conducted by a highly 
skilled tennis coach, for each test to maintain reliability.    
 
 
Table 7-Data Collection Timeline 
Testing Day 1 
48 
h Testing Day 2 
48 
h Testing Day 3 
         
1.  Consent Form   1. Ingest pill (placebo or caffeine); wait 45 minutes   
1. Ingest pill (placebo or caffeine); 
wait 45 minutes 
 
2.  Health Status   
Questionnaire 
   2.  Blood draw   2. Blood draw 
3. Caffeine Intake 
Form   3. 1 hour after pill ingestion, commence testing:   
3. 1 hour after pill ingestion, 
commence testing: 
4. VO2max testing    Treadmill Testing - 45 minutes   
 Treadmill Testing - 45 
minutes 
     120 second transition    120 second transition 
     Tennis Skills Testing - 45 minutes   
 
 Tennis Skills Testing - 
45 minutes 
          
 
Genotyping:  Investigators were blinded to genotype until all subjects completed the 
study.  Furthermore, all genotyping was performed by an investigator not involved with 
the performance testing.  DNA was obtained from whole blood samples via a QiaAmp 





fragment length polymorphism-polymerase chain reaction (RFLP-PCR), as previously 
described (reference).  Briefly, DNA was PCR amplified using the HotStar DNA 
Polymerase Kit (Qiagen) with the forward primer (5‟-
CAACCCTGCCAATCTCAAGCAC-3‟) and reverse primer (5‟-
AGAAGCTCTGTGGCCGAGAAGG-3‟) to generate a 920 bp fragment of the CYP1A2 
gene.  PCR conditions consisted of an initial denaturation at 95°C for 5 minutes, followed 
by 39 cycles at 94°C for 15 seconds, 64.5°C for 1 minute, and 72°C for 1 minute, with a 
final elongation step of 72°C for 10 minutes.  One half of each PCR product was digested 
using the restriction enzyme ApaI (New England Biolabs, Ipswich, MA) as per 
manufacturer‟s instructions.  Digested and undigested PCR products were evaluated in 
parallel via electrophoresis in a 2% agarose gel stained with ethidium bromide, and DNA 
bands were visualized by UV light.  The presence of a 920 bp fragment following ApaI 
digestion identified the A/A genotype, while the presence of 709 bp and 211 bp 
fragments following ApaI digestion identified the C/C genotype.  Because of the 
infrequency of individuals who are homozygous for the C variant, and because of prior 
research from our laboratory suggests that subjects were grouped as AA homozygotes 
and C allele carriers.   
Statistical Analyses 
 Statistical analyses were performed using SPSS 16.0 (Thomson Learning, Pacific 
Grove, CA).  Descriptive data (height, weight, age, VO2max) was compared between 
groups using independent t-tests. 
Potential differences in ball consistency, HR and RPE were assessed using 





placebo) as the within-subjects factor and genotype (AA homozygotes, C allele carriers) 
and gender (male, female) as the between-subjects factors.  For all RMANOVA 
procedures, post-hoc tests were performed using independent and dependent t-tests with a 











 Seven of the 16 subjects were homozygous for the A variant (4 female, 3 male).  
Descriptive characteristics of the two genotype groups are shown in Table 6.  There were 
no significant differences (P > 0.05) between the two groups for height, weight, age, 
VO2max, or caffeine intake.  In AA homozygotes, all 7 subjects were categorized as 
having low caffeine intake (0-150 mg/day), 0 subjects as moderate (151-300 mg/day) and 
0 as high (> 300 mg/day).  Two out of the 9 C allele carriers had moderate intake with 
seven characterized as having low intake.   
 Table 6-Mean Subject Demographics 
   A/A (N=7)  C (N=9)  
   Male (N=3)  Female (N=4)  Male  (N=5)  Female (4)  
Height (cm)  186.8 + 2.97  165.4 + 9.53  185.6 + 6.04  167.9 + 5.44  
Weight (kg)  80.3 + 4.69  62.6 + 13.31  78.9 + 3.74  60.6 + 10.64  
Age (y)  20.7 + 3.06  21.0 + 1.15  20.4 + 1.34  20.8 + 2.06  
VO2max (ml/kg/min)  
53.2 + 1.34  48.2 + 4.71  55.4 + 6.87  49.4 + 6.30  
Caffeine intake (mg/day)  
104.6 + 34.09  103.9 + 38.82  96.1 + 66.08  86.7 + 71.51  
 
 Initial analysis revealed no main effect for gender or any Gender x Treatment 
interaction for the skills test; therefore results for both genders were pooled for statistical 
analysis.  Caffeine significantly (p=0.029) improved performance during the Tennis 
Skills Test - a 1.77% improvement over the placebo treatment.  Figure 1 displays the 
mean total shot successes during the Tennis Skills Test.  There was no genotype effect on 







Figure 1: Mean total shot successes during TST 
*Significant improvement in shot successes compared to placebo (p=0.029) 
 








































Table 8 displays the mean RPE and heart rate values during the exercise tests.  In 
addition, specific RPE values during the treadmill and Tennis Skills Tests are displayed 
in Figure 2.  There was not a main effect for treatment on RPE during the treadmill 
portion of the test (RPE in caffeine trial=11.28 + 1.61; RPE in placebo trial=11.52 + 
1.61).  Similarly, there were no significant main effects or interaction effects for RPE 
following ingestion of caffeine during the Tennis Skills Test (TST) (TST in caffeine 

















Table 8: mean RPE and HR (mean + SD) during the treadmill and Tennis Skills tests divided 
between  genotype and gender.  
 










 RPE AA Female 9.7 + 1.65 9.35 + 1.54 10.25 + 2.55 9.6 + 1.85 
  AA Male 12.07+ 1.21 12.00+ .87 13.07 + 2.14 12.93 + 1.55 
  C Female 11.65 + .84 11.50 + .74 11.1 + .66 11.30 + .35 
  
C Male 11.84 + 1.90 12.96 + 1.01 11.96 + .96 11.52 + 1.12 
HR AA Female 156.00 + 12.78 167.1 + 10.38 160.9 + 24.37 150.7 + 20.22 
  AA Male 137.87 + 4.94 139.47 + 4.08 144.8 + 9.4 155.27+ 9.27 
  C Female 146.75 + 24.44 148.65 + 22.61 147.8 + 21.11 142.35+ 18.17 
  C Male 152.92 + 8.01 155.96 + 9.27 157.48 + 14.60 157.72 + 17.66 
 
Figure 2: Average RPE During Exercise 









































A significant gender effect existed during both the treadmill portion of the testing 
(p=0.020) as well as the TST (p=0.027) for RPE, with women exhibiting a lower RPE 
than men in both situations. 
Although there was not a main effect for Treatment on heart rate during the 
treadmill portion of the tests, there was a trend toward Genotype x Treatment effect 
(p=.056).  On average, caffeine elevated peak heart rate in AA homozygotes (Caffeine = 
154.6 ±17.5 beats/min, Placebo = 148.9 ± 12.9 beats/min) and decreased peak heart rate 
for C allele carriers (Caffeine = 150 ±16.3 beats/min, Placebo = 152.7 ± 15.8 beats/min). 
 There was a trend toward Gender x Treatment effect (p=.065) for heart rate during 
the treadmill portion of the tests.  For both treatments, female subjects had a higher mean 
heart rate as compared to male subjects.  More specifically, following caffeine 
supplementation, female subjects had a mean heart rate of 156.9 ± 5.0 beats/min while 
male subjects had a mean heart rate of 145.4 ± 5.2 beats/min.  Under the placebo 
treatment, the mean heart rate for female subjects was 152.3 ± 5.0 beats/min while male 
subjects had a mean heart rate of 147.7 ± 5.2 beats/min.  Additionally, there was a trend 
toward a Genotype x Gender effect (P=0.056) for heart rate during the treadmill portion 
of the test.  There was a noticeable elevation in heart rate (about 11 beats/min) in AA 
homozygote female subjects.   
 During the Tennis Skills tests, there was also a trend toward a Genotype x Gender 
effect (P=0.070) in which heart rate was augmented in AA homozygote female subjects.  
Mean heart rate response during the treadmill portion of the test and during the tennis 
skills test following ingestion of either caffeine or placebo are displayed in Figure 3.  





supplementation for the exercise tests in AA homozygote female subjects, there was no 
significant difference in the heart rate response between the „caffeine‟ and „placebo‟ 
trials. 
 
Figure 3: Average HR Response During Exercise 









































 Previously published research has clearly established caffeine as an ergogenic aid 
for aerobic activities (4,5,8,9,14,18,20,27,30,32,39,41,46,47,48,56,58,60,64,66,68), 
conversely, the effect of caffeine relative to anaerobic activities indicates a variable 
response (13, 46).  The findings on the effect of caffeine on tennis, a sport that combines 
aspects of aerobic and anaerobic activities has also been equivocal.  A study by Hornery 
et al. (2007) included highly trained male subjects who performed simulated tennis 
matches against a ball machine.  Caffeine was shown to partly attenuate the effects of 
fatigue and increased serve velocity (35).  On the contrary, a study by Ferrauti et al. 
(1997) included male and female subjects who ingested caffeine during a match.  Results 
of this study indicated that caffeine did not positively affect perception ratings or hitting 
accuracy (26).   
 In the current study, caffeine significantly improved performance during the 
Tennis Skills test.  These results support the Hornery (2007) study in that caffeine can 
enhance tennis performance.  However, the current study observed significant ergogenic 
effects with a variety of shots used throughout a tennis match (groundstrokes; approach 
shot; volley) versus ergogenic effects concentrated to service speed (35).  
 To our knowledge, this is the first study to examine the influence of a genetic 
polymorphism on the ergogenic effect of caffeine supplementation during tennis 
performance.  The major findings of the present study are twofold.  There was a 
significant ergogenic effect of caffeine on tennis performance (p=0.029) for both male 





variant of the polymorphism did not experience a more prominent ergogenic effect from 
caffeine than individuals possessing the C variant during tennis, as originally 
hypothesized.     
 A prominent mechanism for enhanced performance detected with caffeine 
supplementation involves stimulation of the central nervous system.  Caffeine has been 
identified to block adenosine receptors and interact with transmission of dopamine, 
thereby inhibiting the negative effects adenosine induces on neurotransmission; arousal 
and pain perception (52,59).  One consistent outcome of caffeine ingestion during 
exercise testing, regardless of mode, intensity, or duration of exercise, is an alteration in 
the subjects‟ perceptual response (24).  The hypoalgesic effects of caffeine result in 
dampened pain perception and reduced perceived exertion during exercise (53).  Other 
potential effects are decreased firing rates of motor units and possibly more sustainable 
and forceful muscle contractions (19) at a given rating of perceived exertion or effort 
sense (38,11,54).  More typically, the alteration in participants‟ perceptual response has 
manifested itself as a reduced RPE at constant exercise intensities (17,28,10,49,23,24,9).  
 For both male and female subjects during both the treadmill portion of the test and 
TST, there were no differences in RPE (p>0.05) among treatments despite the fact that 
caffeine trials elicited enhanced performance during the Tennis Skills test (p=0.029).  
Consequently, it would appear that the subjects perceived identical physiological effort 
despite a higher performance or were able to recruit more motor units at the same 
perceived effort level following caffeine supplementation (40).  This suggests that 
caffeine may have impacted perception of effort in the present study.  Conversely, results 





 As noted, a significant gender effect existed during both the treadmill portion of 
the testing (p=0.020) as well as the TST (p=0.027) relative to RPE.  The female subjects 
tended to perceive work as less strenuous as compared to the male subjects.  Timing of 
data collection may have impacted results.  Both trials for the female subjects took place 
during a short respite in their season.  Data collection for the male subjects, conversely, 
was collected during a heavy training period.  In other studies, subjects were instructed to 
refrain from other exhaustive training for 1-2 days prior to testing (43,46).  This protocol 
could not be followed for this current study as the subjects have specific training 
guidelines as collegiate athletes, which may have impacted results pertaining to RPE.  
Nevertheless, subjects arrived for each testing day in a similar fashion relative to muscle 
fatigue as data was collected during the same segment of the tennis season.  Specific to 
RPE relative to the treadmill portion of the test, it is important to note that 3 of the 8 male 
subjects were novice treadmill users which may have misrepresented the RPE outcome 
during the treadmill portion of the tests for this group. 
 Despite the fact that prior studies have shown elevations in heart rate, our study 
did not observe a main effect for heart rate following caffeine supplementation.  There 
was a strong trend toward gender by treatment effect (p=0.065) for heart rate that was 
observed during the treadmill portion of the test as well as for the TST (p=0.070).  For 
both treatments, female subjects had a higher mean heart rate as compared to male 
subjects.  Additionally, there was a strong trend toward a Treatment by Genotype effect 
for heart rate during the treadmill portion of the exercise tests (P=0.056).  These trends 
were observed predominately in female AA homozygote subjects following caffeine 





mean heart rate for other subjects (see Figure 3).  It is plausible that the small sample size 
of AA female homozygotes (n=4) may have inadvertently influenced both of these 
trends.    
 A recent study conducted in our laboratory (67), indicated an association between 
a CYP1A2 polymorphism (A/C) and the ergogenic effects of caffeine on cycling 
performance.  Performance differences were observed following caffeine 
supplementation with a significant (p<0.05) improvement in a 40k time trial for AA 
homozygotes, but not carriers of the C variant (67).  During the present study, 7 of the 16 
subjects were classified as carriers of the A variant and the other 9 subjects as carriers of 
the C variant.  It was hypothesized that the 7 AA homozygotes would elicit a greater 
performance enhancement following caffeine supplementation as compared to the 
carriers of the C variant.  Contrary to the study conducted by Womack et al. (2009), our 
study did not indicate any difference in performance following caffeine supplementation 
based on subject genotyping (67).   
 The inability to ascertain a significant genotype by treatment interaction for either 
the treadmill portion of the test or Tennis Skills test could be related to the variations 
between protocols.  As the skill component during the Tennis Skills test is variable 
between subjects, this may have resulted in a Type II error.  As evidenced in existing 
literature and supported by the current study, the genetic influence appears to be mode-
specific.  This may indicate that the genetic influence is more pronounced for endurance 
activities and less so for intermittent activities with a strong skill component. 
 Data from our study provides evidence that caffeine significantly and practically 





polymorphism.  As the current study analyzed the ergogenic effect of caffeine on tennis 
performance in terms of average shot successes in a Tennis Skills test, future studies 
should also analyze optimal timing of caffeine ingestion or a multiple dose effect of 











James Madison University 
School of Kinesiology 
Consent for Investigative Procedure 
 
Identification of Investigators & Purpose of Study   
You are being asked to participate in a research study conducted by Courtney S. Klein 
from James Madison University.  The purpose of this study is to determine if caffeine 
enhances tennis performance as well as to determine if genetics explain improvement in 
tennis skill following caffeine supplementation.   
Potential Risks & Benefits 
The investigator perceives the following are possible risks arising from your 
involvement with this study  
If you choose to participate in this study, you will perform three separate exercise tests on 
the treadmill.  Two treadmill tests will be followed by a tennis skills test performed on a 
tennis court.  The investigator perceives the following are possible risks arising from your 
participation in the study: nausea, discomfort, dizziness, and in rare occurrences, heart 
attack, stroke or death. The selection criteria used to obtain participants and the “Health 
Status Questionnaire” are intended to mitigate these risks. In healthy individuals, the risk 
of death during vigorous exercise has been estimated at 1 death per year for every 18,000 
individuals.  
 
Potential benefits from participation in this study include:  
 
1) Helping researchers determine the impact of caffeine supplementation on tennis 
performance. 
 
2) Helping researchers understand the role genetics may play in determining the effectiveness 
of caffeine supplementation. 
 
3) Knowledge of your maximal aerobic capacity (VO2max) 
 
4) Knowledge of whether you are a responder to caffeine supplementation. 
Research Procedures 
Should you decide to participate in this research study, you will be asked to sign this 
consent form once all your questions have been answered to your satisfaction.  This study 
consists of three separate exercise tests performed on a treadmill, two of the three 
treadmill tests to be followed by a tennis skills test performed on a tennis court. 
Furthermore, you will be asked to recall your consumption of caffeinated beverages for 
the previous week. All treadmill tests will be separated by at least 48 hours, so that you 
will be tested three times over a one to two week period, for a total of approximately 5 
hours of testing. The first treadmill test will be performed to volitional exhaustion, 





be breathing through a mouthpiece during all of the exercise tests so that we can analyze 
your expired air to determine how much oxygen you are using. Your heart rate will be 
monitored by a monitor that wraps around your chest.  The second two treadmill tests 
will consist of a 15 minute warm-up at velocities corresponding with 50% of your 
maximal aerobic capacity (VO2max) followed by 45 minutes of intermittent sprints 
(corresponding with 80% of VO2max) and jogging intervals (corresponding with 50% of 
VO2max). 
 
Cardiovascular Endurance (VO2max Test): During the VO2max test, you will begin jogging 
on the treadmill at a speed that is comfortable for you. Every minute during this test, we 
will increase the speed and the elevation of the treadmill until you indicate that you can 
no longer continue. Between test preparation and completion of the exercise test, this test 
should take approximately one hour. 
 
Warm-up & Intermittent Sprints: These tests will be performed in the morning. You will 
be asked to refrain from food and beverages (except water) for 12 hours prior to these 
tests. In addition, you will need to refrain from consumption of caffeine-containing 
beverages (coffee, tea, cola drinks, cocoa) for 24 hours prior to the test. During these two 
tests you will exercise for 15 minutes at velocities corresponding with 50% VO2max 
followed by 45 minutes of intermittent sprints.  The sprints will mirror the intermittent 
nature of a tennis match such that the subject will sprint for 5 seconds at velocities 
corresponding with 80% VO2max and return to a jog corresponding with the warm-up 
speed (50% VO2max) for 15 seconds.  This sequence will be repeated 18 times.  After the 
eighteenth sprint, you will rest for 90 seconds.  You will then do 12 sprints, followed by 
the 15 seconds of jogging between each sprint.  After the 12th sprint, you will rest for 
another 90 seconds.  This sequence will be repeated for 45 minutes.   
 
Both tests will be identical in terms of the speed and elevation of the treadmill. One hour 
prior to the test, you will ingest either caffeine (equivalent to 4-5 six ounce cups of 
coffee) or a placebo in pill form. Neither the investigator nor you will know which 
treatment you received at test time. Between test preparation and completion of these 
exercise tests, each test should take approximately one and a half hours. 
 
Tennis Skills Test: The tennis skills tests will immediately follow the Warm-Up and 
Intermittent Sprint Test.  The test will be organized by sets of six different shots to 
emulate a single game within a set of tennis – 4 ground strokes (the stroke used the most 
within a tennis match), 1 approach shot and 1 volley.  After each set of 6 balls, the 
subject can actively rest at the baseline for 20 seconds, which represents the time allowed 
for rest between tennis points. The 6-ball drill will be repeated 6 times, which represents 
a typical duration and number of balls for 1 game within a set of a realistic tennis match.  
Every two sessions, the player has a 90 second break – which represents the official time 
between a change-over during a match.  The athlete will undergo 9 sessions, which will 
represent 1 set of a typical tennis match.  The key below simplifies the terminology used 





 6 ball drill = 1 point of a typical match 
 6 repetitions of the 6-ball drill = 1 game of a typical match (6 reps of 6-ball drill 
= 1 session) 
 9 sessions = 1 set of a typical match 
 The tennis skills test will be quantified such that each time the ball lands in-
bounds, it will count for 1 point.   Maximum number of points subject may earn 
is 324. 
 
Blood Sampling: We will obtain a very small (1 drop) sample of blood before and after 
each exercise test to determine how much lactic acid you accumulate during the test using 
a finger stick.  In addition, we will obtain about 5 ml of blood (about 1 teaspoon) prior to 
the second two treadmill tests in order to determine the amount of caffeine in your blood.  
These blood samples will be obtained from an arm vein.  
 
DNA Sampling: We will extract a sample of your DNA from your blood sample.  The 
DNA will be stored in our laboratory, but the sample will be coded so that nobody except 
the primary investigator (Courtney Klein) can detect which sample is yours. The DNA 
testing will involve determining your sequence of DNA for a specific gene that is related 
to caffeine metabolism. The results of this genetic testing will only be available to the 
primary investigator and you. These results will not be made public and will be stored in 
a locked file cabinet. We will not use the DNA for any purpose other than determining 
the specific sequence of the CYP1A2 gene.  The DNA sample is subject to court 
subpoena and the participant has the right to request disposal of their DNA sample after 
data collection is completed. 
Confidentiality  
The results of this research will be presented at conferences and published in exercise 
science journals.  The results of this project will be coded in such a way that your identity 
will not be attached to the final form of this study.  The researcher retains the right to use 
and publish non-identifiable data.  However, you can ask that your data be removed from 
the study at any point prior to presentation and publication.  While individual responses 
are confidential, aggregate data will be presented representing averages or generalizations 
about the responses as a whole.  All data will be stored in a secure location accessible 
only to the researcher. Final aggregate results will be made available to participants upon 
request.  Final aggregate results will be made available to you upon request. 
Participation & Withdrawal  
Your participation is entirely voluntary.  You are free to choose not to participate.  
Should you choose to participate, you can withdraw at any time without consequences of 
any kind.  Your right to withdraw includes the right to request that your DNA and blood 






You may have questions or concerns during the time of your participation in this study, 
or after its completion.  If you have any questions about the study, contact Courtney S. 
Klein at kleincs@jmu.edu or by phone at 540-476-2439. 
 
Giving of Consent 
I have read this consent form and I understand what is being requested of me as a 
participant in this study.  I freely consent to participate.  I have been given satisfactory 
answers to my questions.  The investigator provided me with a copy of this form.  I 
certify that I am at least 18 years of age. 
 
 
  Courtney S. Klein 
Name of Participant  (Printed)  Name of Researcher(s)  (Printed) 
   
Name of Participant  (Signed)  Name of Researcher(s)  (Signed) 
   
  Date    Date 
 
   
 
For questions about your rights as a research subject, you may contact the chair of 

















James Madison University 
School of Kinesiology and Recreation Studies 
Health Status Questionnaire 
  
Instructions: Complete each question accurately. All information provided is 
confidential.  
Part I:  General Information  
  
1. Participant Number              Date  
             
 2. Gender (circle one)  Male   Female  
  
3. Date of Birth  (Month/ Day/ Year) 
 
Part II: Medical History  
  
4. Circle any that died of heart attack before age 50:  Father  Mother  Brother  Sister  
Grandparent  
   
  
5. Date of last medical exam: _____________ Last physical fitness test: 
_______________  
  
6. Circle operations you have had:  Back   Heart   Kidney   Eyes    Joint    Neck     Ears     
Hernia     
                                        
        Lung     Other ________________  
  
7. Please circle any of the following for which you have been diagnosed of treated by a 
physician or  
health professional:  
  
Alcoholism     Diabetes       Kidney Problems  
Anemia (sickle cell)   Emphysema      Mental Illness  
Anemia (other)    Epilepsy       Muscular Injury  
Asthma      Eye Problems      Neck Strain  
Back Strain     Gout        Obesity  
Bleeding trait     Hearing Loss      Orthopedic Injuries  
Bronchitis, chronic    Heart Problem      Phlebitis  
Cancer       High Blood Pressure  Rheumatoid arthritis  
Cirrhosis, liver     Hypoglycemia      Stroke  
Concussion     Hyperglycemia     Thyroid problem  
Congenital defect   Infectious Mononucleosis Ulcer  






8. Circle all medications taken in the last six months:  
 
Blood thinner    Epilepsy medication     Nitroglycerin  
Diabetic pill    Heart-rhythm medication   Other __________________  
Digitalis     High-blood pressure medication  
Diuretic     Insulin  
  
9. Any of these health symptoms that occur frequently is the basis for medical attention. 
Circle the  
number indicating how often you have each of the following:  
  
5 = Very often    4 = Fairly often   3 = Sometimes   2 = Infrequently   1= Practically never  
  
a. cough up blood     f. chest pain  
    1   2   3   4   5                   1   2   3   4   5  
  
b. abdominal pain     g. swollen joints  
    1   2   3   4   5                     1   2   3   4   5  
  
c. low back pain     h. feel faint  
    1   2   3   4   5                    1   2   3   4   5  
  
d. leg pain       i. dizziness  
    1   2   3   4   5                   1   2   3   4   5  
  
e. arm or shoulder pain   j. breathless on slight exertion  
    1   2   3   4   5                   1   2   3   4   5  
  
Part III: Health Related Behavior  
  
10. Do you smoke?  Yes No  
  




 40 or more   20-39   10-19   1-9  
  
Cigars or pipes only:   
 
 5 or more or any inhaled  less than 5, none inhaled  
  
12. Do you exercise regularly? Yes No  
  








 1  2  3  4  5  6  7  days per week  
  
14. Can you walk 4 miles briskly without fatigue? Yes No  
  
15. Can you jog 3 miles continuously at a moderate pace without discomfort?  Yes      No  
  




























Caffeine Habits & Frequency Questionnaire 
 
 
This questionnaire asks about your caffeine intake patterns during a typical month. For 
each item listed, respond by indicating your usual intake of that food per Day, Week or 
Month. For example: Coffee. If you drink 2 (8 oz.) cups of coffee every day, respond 2 
Daily. If you think you average 2 cups of coffee a week over the month, respond 2 
Weekly.  
 
For example, if you drink 2 (8 oz.) cups of coffee per week, you would write 2 under 
the week column. 
 
 Description                                                                  Amount  Unit  Daily  Weekly 
Monthly   




Description                                                                     Amount        Unit    Daily   
Weekly   Monthly 
 Coca Cola (1 can = 12 fl. oz)                                                                       12.00               fl.oz. 
 Pepsi (1 can = 12 fl. oz)                                                                               12.00               fl.oz. 
 7-Up (1 can = 12 fl. oz)                                                                               12.00               fl. oz. 
 Root Beer (1 can = 12 fl. oz)                                                                       12.00               fl.oz. 
 Coffee (1 cup = 8 fl. oz)                                                                                8.00              fl.oz. 
 Tea (Circle:  BLACK, GREEN, WHITE) (1 cup = 8 fl. oz.)                        8.00              fl. oz. 
 Hot chocolate or cocoa  (1 cup = 8 fl. oz.)                                                    8.00              fl. oz. 
    Chocolate Milk                                                                                               8.00             fl. oz. 
 Red Bull Energy Drink   (1 can = 8.3 fl. oz.)         8.00             fl. oz.   
 5-Hour Energy  (1 bottle = 2 fl. oz.)         2.00             fl. oz. 
 Monster Energy Drink (1 can = 8.3 fl. oz.)                                                    8.00             fl. oz. 
 Propel + Caffeine  (1 bottle = 8 fl. oz.)                                                         8.00             fl. oz. 
   
Other 
Description             Amount       Unit     Daily   
Weekly   Monthly 
 Caffeine added performance bars (1 serving = 1 bar)                                 1.00                 bar      
   Dark Chocolate Bar (1 bar), M&Ms (1 pkg.)                                                        1.00                       item 
   Milk Chocolate Bar (1 bar), M&Ms (1 pkg.)                      1.00                      item 
   Coffee flavored Ice Cream (1 serving = 1 cup)                                     1.00                       cup 
 
  
Please list your approximate WEEKLY intake of the following: 
 











Borg Rating of Perceived Exertion Scale 
 
Exertion RPE 
no exertion at all 6 
extremely light 7 
 8 




somewhat hard 13 
 14 
hard (heavy) 15 
 16 
very hard 17 
 18 
extremely hard 19 

















Subject # -  MPH at 50% VO2max -             
VO2max -  MPH at 80% VO2max -             
                     
Begin with 15 minute warm up at a speed of 50% VO2max, followed by:       
                     
Intensity Duration 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18   
80% 5 sec                                     
90 
SEC 
50% 15 sec                                     REST 
80% 5 sec                         
90 
SEC       
50% 15 sec                         REST       
80% 5 sec                         
90 
SEC       
50% 15 sec                         REST       
80% 5 sec                         
90 
SEC       
50% 15 sec                         REST       
80% 5 sec                        
90 
SEC       



























































                            
1 (rest 20 
sec)                           
2 (rest 20 
sec)                           
3 (rest 20 
sec)                           
4 (rest 20 
sec)                           
5 (rest 20 
sec)                           
6 (rest 20 
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